DLHCX Mutual Fund

NAV$23.91
Showing 10 of 106 holdings(as of Mar 31, 2026)Top 10 Weight: 43.07%
#TickerNameWeightSharesMkt ValueShare ChgPROSectorPROIndustryPRO
1UCB:BRUcb Sa5.90%130,137$39.21M-Health CarePharmaceuticals
2REGNRegeneron Pharmaceuticals, Inc.5.46%47,000$36.31M-Health CarePharmaceuticals
3PFEPfizer Inc USD 0.054.84%1,145,000$32.15MProProPro
4GILDGilead Sciences Inc4.40%210,000$29.27MProProPro
5ABBVAbbvie Inc Health Care4.09%125,000$27.19MProProPro
6MRKMerck & Co. Inc.3.89%215,000$25.86MProProPro
7AZN:LNAstrazeneca Plc Adr3.86%131,243$25.66MProProPro
84519:JPChugai Pharmaceutical Co. Ltd. Com Stk3.73%450,000$24.82MProProPro
9LLYEli Lilly And Company3.60%26,000$23.91MProProPro
10RHHVF:SMRoche Holding Ag-Genussch 3.30%55,000$21.95MProProPro
See the other 96 holdings of DLHCX
Every position with sector, industry and share changes, as reported Mar 31, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

Top Holdings Themes

UrbanizationInflation ProtectionSocial ImpactInfrastructureBiotechnologyPharmaceuticalsImmunologyOncologyLife Sciences ToolsDigital HealthMedical DevicesSemiconductorsAging Population

DLHCX Mutual Fund Top Holdings

DLHCX holdings top 10 positions. The top 10 holdings account for 43.1% of the fund, led by Ucb Sa at 5.9%, Regeneron Pharmaceuticals, Inc. at 5.5%, Pfizer Inc USD 0.05 at 4.8%.

DLHCX portfolio concentration is moderate, with the top 10 representing 43.1% of total assets. The largest sector exposure is Health Care at 72.4%.

DLHCX sector allocation provides a detailed breakdown. DLHCX overlap tool shows how holdings compare to other funds in your portfolio.